CMS Official Cites OCM as Example of Biosimilar Success
Purva Rawal, PhD, senior advisor and chief strategy officer, Center for Medicare and Medicaid Innovation, addressed attendees at the Association for Accessible Medicines' Access! annual meeting, held in Orlando, Florida, February 15-16.
Experts Discuss How Employers Can Take on HSA HDHP Challenges While Encouraging Value-Based Care
Speaking during a webinar presented by the National Alliance of Healthcare Purchaser Coalitions, experts weighed the pros and cons of employer high-deductible health plans (HDHPs) and outlined steps to address challenges raised.
Payers, Value-based Care Policies Impact Biosimilar Adoption, Cardinal Health Report Finds
Cardinal Health's report, “2022 Biosimilars Report: The U.S. Journey and Path Ahead,” outlines how biosimilars will move beyond their comfort zones in oncology and rheumatology and more boldly into therapeutic areas such as ophthalmology and diabetes care.
How Employers Can Leverage Value, Health Equity Incentives to Address Health Plan Affordability Concerns
Part 1 of a 2-part webinar series by the National Alliance of Healthcare Purchaser Coalitions addressed issues in health care coverage affordability and how equitable health benefits and value-based design can reduce cost while improving employee engagement.
MA Primary Care Payment Models Influenced Telemedicine Usage During the Pandemic, Research Shows
Larger primary care practices in downside risk–only payment models and capitation saw the highest telemedicine utilization rates by their patients enrolled in Medicare Advantage (MA) plans.
2 Clarke Drive Cranbury, NJ 08512